$12.75M Securities Settlement Against Cancer Drug Maker Gains Final Approval
SAN DIEGO — A federal judge in California on June 6 granted final approval of a $12.75 million settlement and awarded $4.25 million in attorney fees to class counsel in a...To view the full article, register now.
Already a subscriber? Click here to view full article